Recce Pharmaceuticals (R9Q.F) Q3 2024 Earnings

30AugConfirmed
Q1 2024
Q3 2024
-0.04
-0.03
-0.03
-0.03

Details

Expected EPS
N/A
Actual EPS
-0.0350563580136
Surprise EPS
-0.04
Surprise Percent
+∞%

Description

Recce Pharmaceuticals (R9Q.F) has reported earnings of -0.0350563580136 per share for Q3 2024.

0 Comments

Share your thoughts